跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Goxaparin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Goxaparin
Approved
STANDARD
Goxaparin
Brawn Laboratories Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5324d50f56389f9a
Company
Brawn Laboratories Ltd.
Type
Standard
Approval Details
Approval Id
5324d50f56389f9a
Drug Approval Philippines Name
Goxaparin
Product Name
Goxaparin
Registration Number
BRP-041-06
Brand Name
Goxaparin
Generic Name
Enoxaparin Sodium
Dosage Form
Solution for Injection (SC)
Dosage Strength
4000 IU anti-Factor Xa (equivalent to 40 mg) / 0.4 mL
Manufacturer
Brawn Laboratories Ltd.
Importer
Ambica International Corporation
Distributor
Applied Pharmaceutical Distribution Inc.
Issuance Date
24 January 2025
Expiry Date
09 December 2025
Pharmacologic Category
Anticoagulant/Antithrombotic Agents
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5324d50f56389f9a
Type
Standard
Back to Philippines FDA Approvals